Residential Psych denied as duplicate or overlapping therapy by UnitedHealthcare?

UnitedHealthcare's specific coverage criteria for residential psych are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why UnitedHealthcare Denies Residential Psychiatric Treatment as Duplicate Therapy

UnitedHealthcare may issue a "duplicate therapy" denial when a claim for residential psychiatric care is submitted while the patient also has active claims or authorizations for another mental health service — for example, outpatient therapy, medication management, or a partial hospitalization program (PHP). The insurer's system flags apparent overlap, but this denial type is frequently a documentation or coding error rather than a genuine clinical duplication.

## Why This Denial Is Appealable

Residential psychiatric treatment is a distinct, defined level of care with its own clinical criteria, intensity of services, and therapeutic milieu. It is not duplicative of outpatient therapy or medication management — these services may occur within or alongside residential treatment as components of a comprehensive care plan, not as substitutes for it. If the "duplicate" service is simply a prescribing clinician's ongoing oversight, or a prior authorization that was superseded by admission, the denial rests on a coding or administrative misclassification. UHC's own medical policy and the applicable level-of-care criteria distinguish residential care from all lower levels. Additionally, MHPAEA prohibits applying a more restrictive anti-duplication standard to mental health care than to analogous medical/surgical care.

## Federal Appeal Framework

• Internal appeal (ACA §2719 / ERISA §503): Submit a written internal appeal within the deadline shown on your EOB (typically 180 days). Request in writing the specific services UHC has identified as duplicative and the clinical policy basis for the determination.
• Clarification request: Separately, request a pre-appeal clinical clarification call with UHC's behavioral health clinical team to resolve whether this is a coding conflict vs. a genuine clinical duplication determination.
• External review: If the internal appeal is denied, independent external review is available within approximately four months of exhausting internal remedies. An IRO will apply objective clinical criteria — not UHC's proprietary duplication logic.
• Expedited review: Available for concurrent denials (patient currently in treatment).

## Documentation to Gather

1. Service-level clarification: Documentation of all concurrent services and a clear explanation of how each is distinct from — and not a substitute for — residential psychiatric care. 2. Treating clinician coordination note: A note from the care team describing how any concurrent services fit within the residential treatment plan rather than replacing it. 3. Diagnosis and admission justification: Current psychiatric diagnosis and clinician documentation of why residential level of care is required. 4. Authorization records: Copies of all active authorizations and a timeline showing whether any "duplicate" authorization was for a preceding level of care that has since been superseded. 5. Prescriber medical-necessity letter: Letter explicitly addressing the claimed duplication and explaining why residential care is the appropriate and non-duplicative level of care.

## Criteria-Mapping Structure

Obtain UHC's published medical policy for residential psychiatric care. List each coverage criterion in one column. In the next column, document the chart evidence satisfying each criterion. Add a separate row specifically addressing the duplication allegation: name the service UHC identified as duplicative, and explain in clinical terms why it does not substitute for residential care. This direct rebuttal structure is essential for both internal and external reviewers.